| 2025-11-26 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.47美元,归母净利润-549.1万美元,同比去年增长-27.46%
|
| 2025-09-19 |
股东大会：
将于2025-10-28召开股东大会
会议内容 ▼▲
- 1.To approve the re-election of Allen Baharaff as a Class II director, to serve as a member of the board of directors (the “Board”) until the annual general meeting to be held in 2028 and until his successor is duly elected and qualified;
2.To approve equity grants to each of our named executive officers and directors, including to our Chief Executive Officer;
3.To approve amendments to the terms of employment of the Company’s President and Chief Executive Officer;
4.To approve a framework for future annual cash bonuses for the Company’s President and Chief Executive Officer, subject to performance matrices to be approved by the Company’s remuneration committee and the Board on an annual basis;
5.To reappoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025 until the 2026 annual general meeting of shareholders (together, the “Proposals”).
|
| 2025-08-28 |
详情>>
业绩披露：
2025年中报每股收益-1.25美元,归母净利润-359.9万美元,同比去年增长-50.33%
|
| 2025-08-18 |
详情>>
股本变动：
变动后总股本547.92万股
|
| 2025-07-24 |
股东大会：
将于2025-08-14召开股东大会
会议内容 ▼▲
- 1.To approve an increase to the Company’s authorized share capital and to amend the Company’s Amended and Restated Articles of Association accordingly (the “Proposal”).
|
| 2025-05-22 |
详情>>
业绩披露：
2025年一季报每股收益-0.62美元,归母净利润-110.4万美元,同比去年增长13.41%
|
| 2025-04-02 |
详情>>
业绩披露：
2022年年报每股收益-127.8美元,归母净利润-1786.6万美元,同比去年增长44.97%
|
| 2025-04-02 |
详情>>
业绩披露：
2024年年报每股收益-8.08美元,归母净利润-751.7万美元,同比去年增长-8.75%
|
| 2025-03-29 |
复牌提示：
2025-03-28 14:42:17 停牌，复牌日期 2025-03-28 14:47:17
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-6.11美元,归母净利润-430.8万美元,同比去年增长12.01%
|
| 2024-10-15 |
股东大会：
将于2024-10-14召开股东大会
会议内容 ▼▲
- 1.To approve an increase to the Company’s authorized share capital and to amend the Company’s Amended and Restated Articles of Association accordingly.
|
| 2024-10-15 |
股东大会：
将于2024-10-21召开股东大会
会议内容 ▼▲
- 1.To approve an increase to the Company’s authorized share capital and to amend the Company’s Amended and Restated Articles of Association accordingly.
|
| 2024-08-30 |
详情>>
拆分方案：
每12.0000合并分成1.0000股
|
| 2024-08-28 |
详情>>
业绩披露：
2024年中报每股收益-0.41美元,归母净利润-239.4万美元,同比去年增长30.06%
|
| 2024-07-11 |
股东大会：
将于2024-07-17召开股东大会
会议内容 ▼▲
- 1.To approve the re-election of each of (a) Prof. Carol L. Brosgart and (b) Mr. Shmuel Nir as a Class I director, to serve as a member of the board of directors (the “Board”) until the annual general meeting to be held in 2027 and until his or her respective successor is duly elected and qualified.
2.To approve a reverse share split of the Company’s Ordinary Shares in the range of up to 15:1, to be effected at the discretion of, and at such ratio and in such date as shall be determined by, the Board, within 12 months of the Meeting; and to amend the Company’s amended and restated articles of association (the “Articles”) accordingly.
3.To ratify and approve a framework of terms and conditions for the extension, renewal and entering into an insurance policy for directors’ and officers’ liability, subject to, and in accordance with, the provisions of the Companies Law 5759-1999 (the “Companies Law”).
4.To reappoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 until the 2025 annual general meeting of shareholders (together, the “Proposals”).
|
| 2024-06-05 |
股东大会：
将于2024-07-10召开股东大会
会议内容 ▼▲
- 1.To approve the re-election of each of (a) Prof. Carol L. Brosgart and (b) Mr. Shmuel Nir as a Class I director, to serve as a member of the board of directors (the “Board”) until the annual general meeting to be held in 2027 and until his or her respective successor is duly elected and qualified.
2.To approve a reverse share split of the Company’s Ordinary Shares in the range of up to 15:1, to be effected at the discretion of, and at such ratio and in such date as shall be determined by, the Board, within 12 months of the Meeting; and to amend the Company’s amended and restated articles of association (the “Articles”) accordingly.
3.To ratify and approve a framework of terms and conditions for the extension, renewal and entering into an insurance policy for directors’ and officers’ liability, subject to, and in accordance with, the provisions of the Companies Law 5759-1999 (the “Companies Law”).
4.To reappoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 until the 2025 annual general meeting of shareholders (together, the “Proposals”).
|
| 2024-05-30 |
详情>>
业绩披露：
2024年一季报每股收益-0.23美元,归母净利润-127.5万美元,同比去年增长30.33%
|
| 2024-04-04 |
详情>>
业绩披露：
2023年年报每股收益-2.5美元,归母净利润-691.2万美元,同比去年增长61.31%
|
| 2023-11-22 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.52美元,归母净利润-489.6万美元,同比去年增长67.85%
|
| 2023-09-13 |
股东大会：
将于2023-09-20召开股东大会
会议内容 ▼▲
- 1.To approve equity grants to each of our named executive officers and directors, including to our Chief Executive Officer.
2.To approve an amendment to the exercise period of outstanding options granted to our Chief Executive Officer.
|
| 2023-08-09 |
股东大会：
将于2023-09-13召开股东大会
会议内容 ▼▲
- 1.To approve equity grants to each of our named executive officers and directors, including to our Chief Executive Officer.
2.To approve an amendment to the exercise period of outstanding options granted to our Chief Executive Officer.
|
| 2023-05-15 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2023-03-30 |
股东大会：
将于2023-05-04召开股东大会
会议内容 ▼▲
- 1.To approve a reverse share split of the Company’s Ordinary Shares in the range of up to 15:1, to be effected at the discretion of, and at such ratio and in such date as shall be determined by, the Board of Directors of the Company, within 12 months of the Meeting; and to amend the Company’s Articles of Association accordingly.
2.To approve the re-election of each of (a) Prof. David Sidransky and (b) Mr. Amir Poshinski as a Class III director, to serve as a member of the Board of Directors until the annual general meeting to be held in 2026 and until their respective successors are duly elected and qualified.
3.To re-approve the Compensation Policy for the Company’s directors and officers, in accordance with the requirements of the Israeli Companies Law, 5759-1999 (the “Companies Law”).
4.To approve amendments to the exercise price and exercise period of outstanding options granted to our directors, including to our Chief Executive Officer.
5.To reappoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 and until the 2024 annual general meeting of shareholders.
|
| 2022-06-22 |
股东大会：
将于2022-06-29召开股东大会
会议内容 ▼▲
- 1.To approve the re-election of Allen Baharaff as a Class II director, to serve as a member of the Board of Directors until the annual general meeting to be held in 2025 and until his respective successor is duly elected and qualified;
2.To approve an increase to the Company’s authorized share capital and to amend the Company’s Amended and Restated Articles of Association accordingly;
3.To reappoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 until the 2023 annual general meeting of shareholders.
|
| 2022-05-17 |
股东大会：
将于2022-06-22召开股东大会
会议内容 ▼▲
- 1.To approve the re-election of Allen Baharaff as a Class II director, to serve as a member of the Board of Directors until the annual general meeting to be held in 2025 and until his respective successor is duly elected and qualified;
2.To approve an increase to the Company’s authorized share capital and to amend the Company’s Amended and Restated Articles of Association accordingly;
3.To reappoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 until the 2023 annual general meeting of shareholders.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-23 |
股东大会：
将于2021-08-23召开股东大会
会议内容 ▼▲
- 1.To approve the re-election of each of (a) Prof. Carol L. Brosgart and (b) Mr. Shmuel Nir as a Class I director, to serve as a member of the Board of Directors until the annual general meeting to be held in 2024 and until their respective successors are duly elected and qualified;
2.To approve an amendment to the Articles of Association of the Company;
3.To approve a grant of options to each of our non-management directors and our President and Chief Executive Officer;
4.To approve the terms of employment of the Company’s President and Chief Executive Officer;
5.To approve an annual cash bonus for the Company’s President and Chief Executive Officer, based on the same formula as determined for other office holders of the Company and performance matrices approved by the Company’s Remuneration Committee and Board of Directors;
6.To approve a framework for future annual cash bonuses for the Company’s President and Chief Executive Officer, subject to performance matrices to be approved by the Company’s Remuneration Committee and Board of Directors on an annual basis;
7.To reappoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 until the 2022 annual general meeting of shareholders.
|
| 2021-08-23 |
股东大会：
将于2021-08-30召开股东大会
会议内容 ▼▲
- 1.To approve the re-election of each of (a) Prof. Carol L. Brosgart and (b) Mr. Shmuel Nir as a Class I director, to serve as a member of the Board of Directors until the annual general meeting to be held in 2024 and until their respective successors are duly elected and qualified;
2.To approve an amendment to the Articles of Association of the Company;
3.To approve a grant of options to each of our non-management directors and our President and Chief Executive Officer;
4.To approve the terms of employment of the Company’s President and Chief Executive Officer;
5.To approve an annual cash bonus for the Company’s President and Chief Executive Officer, based on the same formula as determined for other office holders of the Company and performance matrices approved by the Company’s Remuneration Committee and Board of Directors;
6.To approve a framework for future annual cash bonuses for the Company’s President and Chief Executive Officer, subject to performance matrices to be approved by the Company’s Remuneration Committee and Board of Directors on an annual basis;
7.To reappoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 until the 2022 annual general meeting of shareholders.
|
| 2021-08-05 |
财报披露：
美东时间 2021-08-05 盘前发布财报
|
| 2019-04-04 |
股东大会：
将于2019-05-13召开股东大会
会议内容 ▼▲
- 1.To re-elect Allen Baharaff as a Class II director to serve as a member of the Board until the annual general meeting to be held in 2022 and when his successor has been duly elected and to approve the compensation paid to him as a director;
2.To elect Marshall Heinberg as a Class II director to serve as a member of the Board until the annual general meeting to be held in 2022 and when his successor has been duly elected and to approve the compensation paid to him as an expert external director;
3.To re-elect Prof. Ran Oren as a Class III director to serve as a member of the Board until the annual general meeting to be held in 2020 and when his successor has been duly elected and to approve the compensation paid to him as a director;
4.To approve an increase to the salary of Allen Baharaff, the Company’s President and Chief Executive Officer;
5.To approve an annual cash bonus and related objectives and terms thereof for 2019, for Allen Baharaff, the Company’s President and Chief Executive Officer;
6.To approve the appointment of Allen Baharaff, the Company’s President and Chief Executive Officer as the Chairman of the Board;
7.To approve the grant of options to purchase ordinary shares of the Company to Marshall Heinberg, subject to his election as a director of the Company;
8.To reappoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent registered public accounting firm until the 2020 annual general meeting of shareholders.
|
| 2018-07-19 |
股东大会：
将于2018-08-30召开股东大会
会议内容 ▼▲
- 1.To re-elect Mr. Shmuel Nir as a Class I director to serve as a member of the Board until the annual general meeting to be held in 2021 and to ratify and approve his compensation terms;
2.To re-elect Dr. Carol L. Brosgart as a Class I director to serve as a member of the Board until the annual general meeting to be held in 2021;
3.To approve an annual cash bonus and related objectives and terms thereof for 2018, for the Company’s president and chief executive officer Mr. Allen Baharaff.
4.To approve an increase of the number of shares available for issuance under the Company’s 2013 Incentive Share Option Plan;
5.To approve the grant of options to purchase ordinary shares to the Company’s president and chief executive officer, Mr. Allen Baharaff.
6.To approve the grant of options to purchase ordinary shares to the Company’s non-management directors;
7.To reappoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent registered public accounting firm until the 2019 annual general meeting of shareholders.
|
| 2017-04-27 |
股东大会：
将于2017-06-07召开股东大会
会议内容 ▼▲
- 1.To re-elect Messrs. Chaim Hurvitz and William Marth as Class III directors to serve as members of the Board until the annual general meeting to be held in 2020;
2.To elect Prof. Ran Oren as a Class II director to serve as a member of the Board until the close of the annual general meeting to be held in 2019;
3.To elect Dr. Carol L. Brosgart as a Class I director to serve as a member of the Board until the close of the annual general meeting to be held in 2018;
4.To re-elect Ms. Tali Yaron-Eldar and Dr. David Sidransky as the Company’s external directors for a term of three years, commencing as of June 12, 2017;
5.To approve the compensation terms for directors of the Company;
6.To approve the terms of office and employment of the Company’s president and chief executive officer, Mr. Allen Baharaff;
7.To approve an annual cash bonus and related objectives and terms thereof for 2017 for Mr. Allen Baharaff;
8.To approve the Company’s directors and officers compensation policy;
9.To appoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent registered public accounting firm until the 2018 annual general meeting of shareholders.
|
| 2016-04-20 |
股东大会：
将于2016-05-25召开股东大会
会议内容 ▼▲
- 1. To re-elect Mr. Allen Baharaff as Class II director to serve as a member of the Board until the annual general meeting to be held in 2019;
2. To re-elect Mr. Shmuel Nir as Class I director to serve as a member of the Board until the annual general meeting to be held in 2018;
3. To approve an acceleration and an extension of exercise period of options granted to Dr. Maya Halpern;
4. To approve an amendment to the terms of office and employment of the Company’s President and Chief Executive Officer, Mr. Allen Baharaff;
5. To approve an annual cash bonus and related objectives and terms thereof for 2016 for Mr. Allen Baharaff;
6. To approve the grant of equity awards to Mr. Allen Baharaff;
7. To re-approve the grant of equity awards to Mr. Allen Baharaff and Mr. Chaim Hurvitz, chairperson of the Board, for the year 2015;
8. To approve the grant of equity awards to non-management members of the Board;
9. To appoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent registered public accounting firm until the 2017 annual meeting of shareholders.
|